{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:24:49Z","timestamp":1770413089647,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008940","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000}}],"reference-count":88,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008940.pub2","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T02:02:18Z","timestamp":1418781738000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacotherapies for cannabis dependence"],"prefix":"10.1002","author":[{"given":"Kushani","family":"Marshall","sequence":"first","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Adelaide Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Gowing","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Adelaide Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Adelaide Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[{"name":"Centre for Addiction and Mental Health ; University of Toronto; Translational Addiction Research Laboratory; 33 Russell Street Toronto ON Canada M5S 2S1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10550490802408936","article-title":"A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence","volume":"18","author":"Carpenter","year":"2009","journal-title":"American Journal on Addictions"},{"issue":"1-2","key":"10.1002\/14651858.CD008940.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2010.05.010","article-title":"Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults","volume":"112","author":"Cornelius","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0004|cit4","unstructured":"Frewen A Montebello ME Baillie A Rea F Effects of mirtazapine on withdrawal from dependent cannabis use Proceedings of the 69th Annual Scientific Meeting of the College on Problems of Drug Dependence; June 16-21; Quebec City, Canada 2007 21 FREWEN2007"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0005|cit5","unstructured":"Frewen AR An examination of withdrawal symptoms and their relationship with outcomes in a combined behavioural and pharmacological intervention for dependent cannabis users Thesis (Macquarie University) 2009"},{"issue":"8","key":"10.1002\/14651858.CD008940.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0007|cit7","first-page":"43","article-title":"A double blind, randomised, placebo controlled trial of lithium carbonate for the management of cannabis withdrawal [conference abstract]","volume":"32","author":"Johnston","year":"2013","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0008|cit8","first-page":"45","article-title":"Preliminary findings from a double blind, randomised, placebo controlled trial of lithium carbonate for the management of cannabis withdrawal [conference abstract]","volume":"31","author":"Johnston","year":"2012","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10550490490265280","article-title":"Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium","volume":"13","author":"Levin","year":"2004","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD008940.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/add.12108","article-title":"A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders","volume":"108","author":"Levin","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2009.06.022","article-title":"A placebo-controlled trial of buspirone for the treatment of marijuana dependence","volume":"105","author":"McRae-Clark","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD008940.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1521-0391.2010.00076.x","article-title":"A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder","volume":"19","author":"McRae-Clark","year":"2010","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0015|cit15","first-page":"63","article-title":"Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: A pilot study","volume":"6","author":"Penetar","year":"2012","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/00952990.2013.819362","article-title":"Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: A double-blind placebo-controlled study","volume":"40","author":"Weinstein","year":"2014","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/10550490701389658","article-title":"Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia","volume":"16","author":"Akerele","year":"2007","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1002\/14651858.CD008940.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jsat.2012.08.223","article-title":"Initiation of abstinence in adolescents treated for marijuana use disorders","volume":"44","author":"Brown","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD008940.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1369-1600.2012.00461.x","article-title":"A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers","volume":"18","author":"Cooper","year":"2013","journal-title":"Addiction Biology"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-4603(98)00050-1","article-title":"Fluoxetine versus placebo for the marijuana use of depressed alcoholics","volume":"24","author":"Cornelius","year":"1999","journal-title":"Addictive Behaviours"},{"issue":"11","key":"10.1002\/14651858.CD008940.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.addbeh.2008.02.001","article-title":"Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence","volume":"33","author":"Cornelius","year":"2008","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00207459408985987","article-title":"Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco","volume":"76","author":"Daynes","year":"1994","journal-title":"International Journal of Neuroscience"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1753-2000-3-11","article-title":"The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial","volume":"3","author":"Findling","year":"2009","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"issue":"4","key":"10.1002\/14651858.CD008940.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jsat.2011.09.010","article-title":"Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders","volume":"42","author":"Hirschtritt","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00004583-199802000-00009","article-title":"Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency","volume":"37","author":"Geller","year":"1998","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0278-5846(92)90080-X","article-title":"Early findings from a pharmacokinetically designed double-blind and placebo-controlled study of lithium for adolescents comorbid with bipolar and substance dependency disorders","volume":"16","author":"Geller","year":"1992","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/00207450600753998","article-title":"Combined cannabis\/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide","volume":"116","author":"Gillman","year":"2006","journal-title":"International Journal of Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1521-0391.2009.00027.x","article-title":"N-Acetylcysteine (NAC) in young marijuana users: An open-label pilot study","volume":"19","author":"Gray","year":"2010","journal-title":"American Journal on Addictions"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130000657","article-title":"Bupropion SR worsens mood during marijuana withdrawal in humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00213-002-1279-8","article-title":"Interaction between naltrexone and oral THC in heavy marijuana smokers","volume":"166","author":"Haney","year":"2003","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-002-1210-3","article-title":"Nefazodone decreases anxiety during marijuana withdrawal in humans","volume":"165","author":"Haney","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-010-1888-6","article-title":"Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse","volume":"211","author":"Haney","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1038\/npp.2011.291","article-title":"Nabilone decreases marijuana withdrawal and relapse in the human laboratory","volume":"36","author":"Haney","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD008940.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/npp.2013.54","article-title":"Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse","volume":"38","author":"Haney","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"S508","DOI":"10.1038\/npp.2013.281","article-title":"Marijuana withdrawal and relapse in the human laboratory: Effect of zolpidem alone and in combination with nabilone","volume":"38","author":"Haney","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0376-8716(02)00084-4","article-title":"Effects of oral THC maintenance on smoked marijuana self-administration","volume":"67","author":"Hart","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/2045125313512324","article-title":"Baclofen in the management of cannabis dependence syndrome","volume":"4","author":"Imbert","year":"2014","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10550490701861177","article-title":"Use of dronabinol for cannabis dependence: two case reports and review","volume":"17","author":"Levin","year":"2008","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/10550490600860635","article-title":"Buspirone for treatment of marijuana dependence: a pilot study","volume":"15","author":"McRae","year":"2006","journal-title":"American Journal on Addictions"},{"issue":"12","key":"10.1002\/14651858.CD008940.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1176\/appi.ajp.163.12.2096","article-title":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes","volume":"163","author":"Robinson","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.psychres.2011.05.001","article-title":"Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes","volume":"188","author":"Sevy","year":"2011","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.biopsych.2010.03.033","article-title":"Baclofen in cannabis dependence syndrome","volume":"68","author":"Nanjayya","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0924-9338(11)71821-1","article-title":"Baclofen in cannabis dependence syndrome - a open-label study and a brief follow up","volume":"26 Suppl 1","author":"Subodh","year":"2011","journal-title":"European Psychiatry, Abstracts of the 19th European Congress of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pbb.2010.12.013","article-title":"The safety of modafinil in combination with oral 9-tetrahydrocannabinol in humans","volume":"98","author":"Sugarman","year":"2011","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.drugalcdep.2007.10.020","article-title":"Atomoxetine for treatment of marijuana dependence: A report on the efficacy and high incidence of gastrointestinal adverse effects in a pilot study","volume":"94","author":"Tirado","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","article-title":"Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal","volume":"117","author":"Vandrey","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1-2","key":"10.1002\/14651858.CD008940.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users","volume":"128","author":"Vandrey","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD008940.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/070674370805300610","article-title":"Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: A double-blind randomized controlled trial","volume":"53","author":"Nimwegen","year":"2008","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/0269881108089584","article-title":"Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study","volume":"23","author":"Winstock","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Agrawal A Pergadia ML Lynskey MT Is there evidence for symptoms of cannabis withdrawal in the National Epidemiologic Survey of Alcohol and Related Conditions? American Journal on Addictions 2008 199 208","DOI":"10.1080\/10550490802019519"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Beauvais F Jumper-Thurman P Helm H Plested B Burnside M Surveillance of drug use among American Indian adolescents: patterns over 25 years Journal of Adolescent Health 2004 493 500","DOI":"10.1016\/S1054-139X(03)00340-9"},{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737175.8.3.479","article-title":"Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence","volume":"8","author":"Benyamina","year":"March 2008","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Budney AJ Moore BA Vandrey RG Hughes JR The time course and significance of cannabis withdrawal Journal of Abnormal Psychology 2003 393 402","DOI":"10.1037\/0021-843X.112.3.393"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Budney AJ Hughes JR The cannabis withdrawal syndrome Current Opinion in Psychiatry 2006 233 8","DOI":"10.1097\/01.yco.0000218592.00689.e5"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Budney AJ Roffman R Stephens RS Walker D Marijuana dependence and its treatment Addiction Science & Clinical Practice 2007 4 16","DOI":"10.1151\/ASCP07414"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"Chung T Martin CS Cornelius JR Clark DB Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents Addiction 2008 787 99","DOI":"10.1111\/j.1360-0443.2008.02158.x"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Clough AR D'Abbs P Cairney S Gray D Maruff P Parker R Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities Drug and Alcohol Review 2004 381 90","DOI":"10.1080\/09595230412331324509"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Copeland J Swift W Rees V Clinical profile of participants in a brief intervention program for cannabis use disorder Journal of Substance Abuse Treatment 2001 45 52","DOI":"10.1016\/S0740-5472(00)00148-3"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2217\/npy.13.90","article-title":"Cannabis use, harms and the management of cannabis use disorder","volume":"4","author":"Copeland","year":"2014","journal-title":"Neuropsychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Copersino ML Boyd SJ Tashkin DP Huestis MA Heishman SJ Dermand JC Cannabis withdrawal among non-treatment-seeking adult cannabis users American Journal on Addictions 2006 8 14","DOI":"10.1080\/10550490500418997"},{"issue":"2","key":"10.1002\/14651858.CD008940.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.psc.2012.03.003","article-title":"State of the art treatments for cannabis dependence","volume":"35","author":"Danovitch","year":"2012","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0065|cit65","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition dsm.psychiatryonline.org 2013","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0066|cit66","unstructured":"European Monitoring Centre for Drugs and Drug Addiction Cannabis problems in context: understanding the increase in European treatment demands http:\/\/www.emcdda.europa.eu\/html.cfm\/index34898EN.html November 2004 81 92"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0067|cit67","unstructured":"European Monitoring Centre for Drugs and Drug Addiction Cannabis Drug Profile http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/cannabis"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Gruber AJ Pope HG Hudson JI Yurgelun-Todd D Attributes of long-term heavy cannabis users: a case-control study Psychological Medicine 2003 1415 22","DOI":"10.1017\/S0033291703008560"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0069|cit69","volume-title":"The health and psychological effects of cannabis use","author":"Hall","year":"2001"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Hall W Degenhardt L Adverse health effects of non-medical cannabis use Lancet 2009 1383 91","DOI":"10.1016\/S0140-6736(09)61037-0"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Hart CL Increasing treatment options for cannabis dependence: A review of potential pharmacotherapies Drug and Alcohol Dependence 2005 147 59","DOI":"10.1016\/j.drugalcdep.2005.03.027"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Hasin DS Keyes KM Alderson D Wang S Aharonovich E Grant BF Cannabis withdrawal in the United States: Results from NESARC Journal of Clinical Psychiatry 2008 1354 63","DOI":"10.4088\/JCP.v69n0902"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0073|cit73","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD008940.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis","volume":"68","author":"Large","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.comppsych.2012.12.021","article-title":"Cannabis use and cannabis use disorders among individuals with mental illness","volume":"54","author":"Lev-Ran","year":"2013","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1521-0391.2013.00321.x","article-title":"Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample","volume":"22","author":"Lev-Ran","year":"2013","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-011-2480-4","article-title":"Characterizing smoking topography of cannabis in heavy users","volume":"220","author":"McClure","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0078|cit78","doi-asserted-by":"crossref","unstructured":"Milin R Manion I Dare G Walker S Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: A pilot study Journal of the American Academy of Child & Adolescent Psychiatry 2008 174 9","DOI":"10.1097\/chi.0b013e31815cdd73"},{"issue":"3","key":"10.1002\/14651858.CD008940.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1465-3362.2009.00132.x","article-title":"An overview of systematic reviews on cannabis and psychosis: Discussing apparently conflicting results","volume":"29","author":"Minozzi","year":"May 2010","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Nordstrom BR Levin FR Treatment of cannabis use disorders: A review of the literature American Journal on Addictions 2007 331 42","DOI":"10.1080\/10550490701525665"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0081|cit81","article-title":"Treatment Episode Data Set (TEDS): 1996-2006. National Admissions to Substance Abuse Treatment Services","volume-title":"www.oas.samhsa.gov\/copies.cfm","author":"Substance Abuse and Mental Health Services Administration","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD008940.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874473710801010081","article-title":"The chronic effects of cannabis on memory in humans: A review","volume":"1","author":"Solowij","year":"2008","journal-title":"Current Drug Abuse Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008940.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub4","article-title":"Nicotine replacement therapy for smoking cessation","author":"Stead","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/add.12508","article-title":"Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study","volume":"109","author":"Pol","year":"2014","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Vandrey R Haney M Pharmacotherapy for cannabis dependence: How close are we? CNS Drugs 2009 543 53","DOI":"10.2165\/00023210-200923070-00001"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"Wagner FA Anthony JC From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol Neuropsychopharmacology 2002 479 88","DOI":"10.1016\/S0893-133X(01)00367-0"},{"key":"10.1002\/14651858.CD008940.pub2-BIB0088|cit88","unstructured":"United Nations Office on Drugs and Crime World Drug Report 2013 www.unodc.org"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008940.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008940.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:25:35Z","timestamp":1628547935000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008940.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":88,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008940.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008940.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}